Kenichi Mori

Gilteritinib, a FLT3/AXL inhibitor, shows antileukemic activity in mouse models of FLT3 mutated acute myeloid leukemia

Masamichi Mori, Naoki Kaneko, Yoko Ueno et al. · Investigational New Drugs · 2017 · 249 citations · Full text

Rab27b Is Expressed in a Wide Range of Exocytic Cells and Involved in the Delivery of Secretory Granules Near the Plasma Membrane

Hiroshi Gomi, Kenichi Mori, Shigeyoshi Itohara et al. · Molecular Biology of the Cell · 2007 · 113 citations · Full text

Protein Secretion, Molecular Regulation, Molecular Biology +21

Binding and Aggregation Mechanism of Amyloid β-Peptides onto the GM1 Ganglioside-Containing Lipid Membrane

Tyuji Hoshino, Md. Iqbal Mahmood, Kenichi Mori et al. · The Journal of Physical Chemistry B · 2013 · 78 citations

Amyloid β, Proteinlipid Interaction, Glycobiology +18

Gilteritinib is a clinically active FLT3 inhibitor with broad activity against FLT3 kinase domain mutations

Theodore C. Tarver, Jason E. Hill, Leena Rahmat et al. · Blood Advances · 2020 · 76 citations · Full text

Formation of GM1 Ganglioside Clusters on the Lipid Membrane Containing Sphingomyeline and Cholesterol

Kenichi Mori, Md. Iqbal Mahmood, Saburo Neya et al. · The Journal of Physical Chemistry B · 2012 · 67 citations

Proteinlipid Interaction, Lipid Biophysics, Engineering +18